Celosomy is associated with prenatal exposure to cyclooxygenase inhibitors

Pharmacological Research

Volumn 53, Issue 3, 2006, Pages 287-292

  Burdan, Franciszek ^a   Szumilo, Justyna ^a   Dudka, Jaroslaw ^a   Korobowicz, Agnieszka ^a   Klepacz, Robert ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Abdominal wall defect; Celosomy; Congenital umbilical hernia; COX inhibitors; Coxibs; Cyclooxygenase; Gastroschisis; NSAID; Omphalocele

Indexed keywords

5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; 5,5 DIMETHYL 3 (3 FLUOROPHENYL) 4 ( 4 METHYLSULPHONYL)PHENYL 2(5H) FURANONE; ACETYLSALICYLIC ACID; CAFFEINE; CYCLOOXYGENASE 2 INHIBITOR; FURANONE DERIVATIVE; IBUPROFEN; PARACETAMOL; PHENAZONE DERIVATIVE; PIROXICAM; PROPYPHENAZONE; PROSTAGLANDIN SYNTHASE INHIBITOR; TOLMETIN; UNCLASSIFIED DRUG;

ABDOMINAL WALL DEFECT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY HEIGHT; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SELECTIVITY; FETUS; FETUS WEIGHT; GASTROSCHISIS; MATERNAL AGE; NONHUMAN; OMPHALOCELE; POLLUTION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; STATISTICAL ANALYSIS;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ASPIRIN; CYCLOOXYGENASE INHIBITORS; FEMALE; FETAL WEIGHT; FETUS; GASTROSCHISIS; HERNIA, UMBILICAL; MATERNAL-FETAL EXCHANGE; PIROXICAM; PREGNANCY; RATS; TOLMETIN;

EID: 32644461410     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2005.12.006     Document Type: Article

References (36)

1. C. Roux, P. Guittin, J. Stadle, A. Morin, C. Boutemy, and D. Hiss Comparative atlas of external malformations in laboratory animals and humans Bruxelles, De Boeck & Larcier 2003 123 144
2. ICBD. International Clearinghouse for Birth Defects Monitoring Systems, http://www.icbd.org/definition.htm [last access July 05 2005].
3. C.P. Trofs, E.A. Katz, T.F. Bateson, P.K. Lam, and C.J. Curry Maternal medications and environmental exposures as risk factor for gastroschisis Teratology 54 1996 84 92
4. M.M. Werler, A.A. Mitchell, and S. Shapiro First trimester maternal medication use in relation to gastroschisis Teratology 45 1992 361 367
5. M.M. Werler, A.A. Mitchell, and S. Shapiro Demographic, reproductive, medical, and environmental factors in relation to gastroschisis Teratology 45 1992 353 360
6. S. Pampfer, and C. Streffer Prenatal death and malformations after irradiation of mouse zygotes with neutrons or X-rays Teratology 37 1988 599 607
7. J. Sasaki, A. Yamaguchi, Y. Nabeshima, S. Shigemitsu, N. Mesaki, and T. Kubo Exercise at high temperature causes maternal hyperthermia and fetal anomalies in rats Teratology 51 1995 233 236
8. J. Singh Gastroschisis is caused by the combination of carbon monoxide and protein-zinc deficiencies in mice Birth Defects Res Part B Dev Reprod Toxicol 68 2003 355 362
9. M.B. Forrester, and R.D. Merz Epidemiology of abdominal wall defects, Hawaii, 1986-1997 Teratology 60 1999 117 123
10. L.D. Botto, J.D. Erickson, J. Mulinare, M.C. Lynberg, and Y. Liu Maternal fever, multivitamin use, and selected birth defects: evidence of interaction? Epidemiology 13 2002 485 488
11. J.C. Cook, C.F. Jacobson, F. Gao, M.S. Tassinari, M.E. Hurtt, and J.M. DeSesso Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits Birth Defects Res Part B Dev Reprod Toxicol 68 2003 5 26
12. F. Burdan Developmental toxicity evaluation of ibuprofen and tolmetin administered in triple daily doses to Wistar CRL:(WI)WUBR rats Birth Defects Res Part B Dev Reprod Toxicol 71 2004 321 330
13. F. Burdan Comparison of developmental toxicity of selective and non-selective cyclooxygenase-2 inhibitors in CRL:(WI)WUBR Wistar rats - DFU and piroxicam study Toxicology 211 2005 12 25
14. G.D. Cappon, J.C. Cook, and M.E. Hurtt Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closure Birth Defects Res Part B Dev Reprod Toxicol 68 2003 47 56
15. F. Burdan Intrauterine growth retardation and lack of teratogenic effects of prenatal exposure to the combination of paracetamol and caffeine in Wistar rats Reprod Toxicol 17 2003 51 58
16. F. Burdan Effects of prenatal exposure to combination of acetaminophen, isopropylantipyrine and caffeine on intrauterine development in rats Hum Exp Toxicol 21 2002 25 31
17. F. Burdan, J. Szumilo, J. Dudka, R. Klepacz, M. Blaszczak, and M. Solecki Morphological studies in modern teratological investigations Folia Morphol 64 2005 1 8
18. DevTox. http://www.devtox.org/nomenclature/organ.php [last access March 05 2005].
19. J.M. DeSesso Comparative embryology RD. Hood Handbook of developmental toxicology 1997 CRS Press New York, NY 117 174
20. H.E. Hoyme, M.C. Higginbottom, and K.L. Jones The vascular pathogenesis of gastroschisis: Intrauterine interruption of the omophalomesenteric artery J Pediatr 98 1981 228 231
21. F. Burdan Developmental effects of propyphenazone in analgesic and antipyretic combination with caffeine or paracetamol Hum Exp Toxicol 23 2004 235 244
22. F. Burdan, J. Dudka, J. Szumilo, A. Korobowicz, and L. Klepacz Prenatal effect of DuP-697 - the irreversible, highly selective cyclooxygenase-2 inhibitor Reprod Toxicol 17 2003 413 419
23. G. Dannhardt, and W. Kiefer Cyclooxygenase inhibitors - current status and future prospects Eur J Med Chem 36 2001 109 126
24. K.M. Stanfield, R.R. Bell, A.R. Lisowski, M.L. English, S.S. Saldeen, and K.N. Khan Expression of cyclooxygenase-2 in embryonic and fetal tissues during organogenesis and late pregnancy Birth Defects Res Part A Clin Mol Teratol 67 2003 54 58
25. R.D. Streck, S.W. Kumpf, T.R. Ozolins, and D.B. Stedman Rat embryos express transcripts for cyclooxygenase-1 and carbonic anhydrase-4, but not for cyclooxygenase-2, during organogenesis Birth Defects Res Part B Dev Reprod Toxicol 68 2003 57 69
26. D. Riendeau, M.D. Percival, S. Boyce, C. Brideau, S. Charleson, and W. Cromlish Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor Br J Pharmacol 121 1997 105 117
27. F. Ariyuki, H. Ishihara, K. Higaki, and M. Yasuda A study of fetal growth retardation in teratological testes: relationship between body weight and ossification of the skeleton in rat fetuses Teratology 26 1982 263 267
28. I. Chahoud, and F.J.R. Paumgartten Relationship between fetal body weight of Wistar rats at term and the extent of skeletal ossification Braz J Med Biol Res 38 2005 565 575
29. I. Chahoud, A. Ligesa, L. Dietzel, and A.S. Faqi Correlation between maternal toxicity ad embryo/fetal effects Reprod Toxicol 13 1999 375 381
30. M.S. Christian Test methods for assessing female reproductive and developmental toxicology A.W. Hayes Principles and methods of toxicology fourth ed. 2001 Taylor & Francis Philadelphia, PN 1301 1381
31. R. Jelinek The contribution of new findings and ideas to the old principles of teratology Reprod Toxicol 20 2005 295 300
32. E. Kozer, A.M. Costei, R. Boskovic, I. Nulman, S. Nikfar, and G. Koren Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis Birth Defects Res B Dev Reprod Toxicol 68 2003 70 84
33. M.L. Martinez-Frias, E. Rodriguez-Pinilia, and L. Prieto Prenatal exposure to salicylates and gastroschisis: a case-control study Teratology 56 1997 241 243
34. M.M. Werler, J.E. Sheehan, and A.A. Mitchell Maternal medication use and risks of gastroschisis and small intestinal atresia Am J Epidemiol 155 2002 26 31
35. F. Burdan, Z. Siezieniewska, G. Kis, and T. Blacharski Embryofetotoxicity of acetaminophen in in-vivo experimental model Ann Univ Mariae Curie Sklodowska [Med] 56 2001 89 95
36. F. Burdan Somatic and skeleton development of rat foetuses following in-utero exposure to isopropylantipyrine (propyphenazone) during the second trimester of gestation Folia Morphol 59 2000 317 322